2 results
Approved WMOCompleted
The aim of the present study is to test light treatment through the ear on the biological clock, sleep-wake rhythm, our alertness and functioning.
Approved WMOCompleted
This is an exploratory study to assess changes in colonic inflammation after 8 weeks of treatment with tofacitinib (XELJANZ) 2 x 5 mg BID in patients with moderate to severely active UC.